Trinity Biotech ADR buy StockNews.com
Start price
05.03.23
/
50%
€0.95
Target price
05.03.24
-
Performance (%)
-55.37%
End price
06.03.24
-
Summary
This prediction is currently being closed. The BUY prediction by StockNews_com for Trinity Biotech ADR is performing very badly with a performance of -55.37%. StockNews_com has a follow-up prediction for Trinity Biotech ADR where he still thinks Trinity Biotech ADR is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Trinity Biotech ADR | - | - | - |
iShares Core DAX® | 3.054% | 0.066% | 16.889% |
iShares Nasdaq 100 | 4.389% | -2.130% | 31.443% |
iShares Nikkei 225® | 5.386% | -0.624% | 16.546% |
iShares S&P 500 | 2.955% | -0.948% | 26.821% |
Comments by StockNews_com for this prediction
In the thread Trinity Biotech ADR diskutieren
Trinity Biotech plc (NASDAQ: TRIB) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for TRIB provided by MarketBeat
In the thread Trading Trinity Biotech ADR
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten